Additional Listing
January 23 2004 - 5:44AM
UK Regulatory
RNS Number:5716U
GW Pharmaceuticals PLC
23 January 2004
GW Pharmaceuticals plc ("the Company")
Option exercise and application to AIM
Pursuant to the exercise by a Consultant of a option over 8,000 new ordinary
shares of 0.1p each in the Company ("New Ordinary Shares") at a price of 20.52p
per share, the Company has today issued and allotted the New Ordinary Shares and
applied for them to be admitted to the Alternative Investment Market of the
London Stock Exchange. Such admission is expected to become effective on
Thursday 29 January 2004.
23 January 2004
This information is provided by RNS
The company news service from the London Stock Exchange
END
LISBBGDBDSDGGSX